Thymidine phosphorylase: A two-face janus in anticancer chemotherapy

Current Cancer Drug Targets

Volumn 1, Issue 2, 2001, Pages 141-153

  Pocher, F ^a   Spadari, S ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENDOTHELIAL CELL GROWTH FACTOR; ENZYME INHIBITOR; THYMIDINE PHOSPHORYLASE;

ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; REVIEW; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; THYMIDINE PHOSPHORYLASE;

EID: 0035427998     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009013334232     Document Type: Article

References (90)

1. Folkman, J.; Shing, Y. Angiogenesis. J. Biol. Chetn. 1992,267, 10931-10934.
2. Folkman, J. The Influence of Angiogenesis Research on Management of Patients with Breast Cancer. Breast Cancer Res. Treat. 1995, 36, 109-118.
3. Cherrington, J. M; Strawn, L. M.; Shawver, L. K. New Paradigms for the Treatment of Cancer: The Role of AntiAngiogenesis Agents. Adv. Cancer Res. 2000, 79, 1-38.
4. Folkman, J. Tumor Angiogenesis: Therapeutic Implications. N. Engl. J. Med. 1971,255, 1182-1186.
5. Seghezzi, G.; Patel, S.; Ren, C. J.; Gualandris, A.; Pintucci, G.; Robbins, E. S.; Shapiro, R. L.; Galloway, A. C.; Rifkin, D. B.; Mignatti, P. Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis. J. Cell. Biol. 1998, 29, 1659-1673.
6. Hanahan, D. Signaling Vascular Morphogenesis and Maintenance. Science 1997, 277, 48-50.
7. Miyazono, K.; Okabe, T.; Urabe, A.; Takaku, F.; Heldin, C.-H. Purification and Properties of an Endothelial Cell Growth Factor from Human Platelets. J. Biol. Chem. 1987,262, 4098-4103.
8. Ishikawa, F.; Miyazono, K.; Hellman, U.; Drexler, H.; Wernstedt, C.; Hagiwara, K.; Usuki, K.; Takaku, F.; Risau, W.; Heldin, C.-H. Identification of Angiogenic Activity and the Cloning and Expression of PlateletDerived Endothelial Cell Growth Factor. Nature 1989, 338, 557-562.
9. Folkman, J. Angiogenesis and Angiogenesis Inhibition: An Overview. EXS 1997, 79, 1-8.
10. O'Reilly, M. S.; Boehm, T.; Shing, Y.; Fukai, N.; Vasios, G.; Lane, W. S.; Flynn, E.; Birkhead, J. R.; Olsen, B. R.; Folkman, J. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth. Cell 1997, 88, 277285.
11. O'Reilly, M. S.; Holmgren, L.; Shing, Y.; Chen, C.; Rosenthal, R. A.; Moses, M.; Lane, W. S.; Cao, Y.; Sage, E. H.; Folkman, J. Angiostatin: A Novel Angiogenesis Inhibitor that Mediates the Suppression of Métastases by a Lewis Lung Carcinoma. Cell 1994, 79, 315-328.
12. Miyazono, K.; Heldin, C. H. High-Yield Purification of Platelet-Derived Endothelial Cell Growth Factor: Structural Characterization and Establishment of a Specific Antiserum. Biochemistry 1989,25, 1704-1710.
13. Hagiwara, K..; Stenman, G.; Honda, H.; Sahlin, P.; Andersson, A.; Miyazono, K.; Heldin, C. H.; Ishikawa, F.; Takaku, F. Organization and Chromosomal Localization of the Human Platelet-Derived Endothelial Cell Growth Factor Gene. Mol Cell Biol. 1991, 2125-2132.
14. Usuki, K.; Saras, J.; Waltenberger, J.; Miyazono, K.; Pierce, G.; Thomason, A.; Heldin, C.-H. Platelet-Derived Endothelial Cell Growth Factor Has Thymidine Phosphorylase Activity. Biochem. Biophys. Res. Commun. 1992, 184, 1311-1316.
15. Spraggon, G.; Stuart, D.; Ponting, C.; Finnis, C.; Sleep, D.; Jones, Y. Crystallization And X-Ray Diffraction of Recombinant Platelet-Derived Endothelial Cell Growth Factor. J. Mol. Biol. 1993, 234, 879-880.
16. Walter, M. R.; Cook, W. J.; Brent Cole, L.; Short, S. A.; Koszalka, G. W.; Krenitsky, T. A.; Ealick, S. E. ThreeDimensional Structure of Thymidine Phosphorylase from Escherichia Coli at 2.8 A Resolution. J. Biol. Chem. 1990,265, 14016-14022.
17. Moghaddam, A.; Bicknell, R. Expression of PlateletDerived Endothelial Cell Growth Factor in Escherichia Coli and Confirmation of its Phosphorylase Activity. Biochemistry 1992,31, 12141-12146.
18. Finnis, C.; Dodsworth, N.; Pollitt, C. E.; Sleep, D. Thymidine Phosphorylase Activity of Platelet-Derived Endothelial Cell Growth Factor is Responsible for Endothelial Cell Mitogenicity. Enr. J. Biochem. 1993, 2/2, 201-210.
19. Brown, N. S.; Bicknell, R. Thymidine Phosphorylase, 2Deoxy-D-Ribose and Angiogenesis. Biochem. J. 1998, 334, 1-8.
20. Miyazono, K.; Takaku, F. Platelet-Derived Endothelial Cell Growth Factor: Structure and Function. Jpn. Cire. J. 1991,55, 1022-1026.
21. Friedkin, M.; Roberts, D. The Enzymatic Synthesis of Nucleosides. Thymidine Phosphorylase in Mammalian Tissue. J. Biol. Chem. 1953, 207, 245-256.
22. Kornberg, A.; Baker, T. A. DNA Replication; Freeman and Co.: New York, 1991.
23. Hübscher, U.; Spadari, S. DNA Replication and Chemotherapy. Physiol. Rev. 1994, 74, 259-304.
24. Desgranges, C.; Razaka, G.; Rabaud, M.; Bricaud, H. Catabolism of Thymidine in Human Blood Platelets. Purification and Properties of Thymidine Phosphorylase. Biochim. Biophys. Ada 1981, 054, 211218.
25. Piper, A. A.; Fox, R. M. Biochemical Basis for the Differential Sensitivity of Human T- and B-Lymphocyte Lines to 5-FIuorouracil. Cancer Res. 1982,42, 37533760.
26. Desgranges, C.; Razaka, G.; Rabaud, M.; Bricaud, H.; Balzarini, J.; De Clercq, E. Phosphorolysis Of (E)-5-(2Bromovinyl)-2'-Deoxyuridine (BVDU) and other 5-Substituted-2'-Deoxyuridines by Purified Human Thymidine Phosphorylase and Intact Blood Platelets. Biochem. Pharmacol. 1983, 32, 3583-3590.
27. Verri, A.; Focher, F.; Duncombe, R. J.; Basnak, I.; Walker, R. T.; Coe, P. L.; De Clercq, E.; Andrei, G.; Snoeck, R.; Balzarini, J.; Spadari, S. Anti-(Herpes Vimplex Virus) Activity of 4'-Thio-2'deoxyuridines: A Biological Investigation for Viral and Cellular Target-Enzymes. Biochem. J. 2000, 351, 319-326.
28. Spadari, S.; Maga, G.; Verri, A.; Focher, F. Molecular Basis for the Antiviral and Anticancer Activities of Unnatural L-Nucleosides. Exp. Opin. Invest. Drugs 1998, 7. 1285-1300.
29. Spadari, S.; Ciarrocchi, G.; Focher, F.; Verri, A.; Maga, G.; Arcamone, F.; lafrate, E.; Manzini, S.; Garbesi, A.; Tondelli, L. 5-Iodo-2'-Deoxy-L-Uridine (L-IDU) and (E)-5-(2-Bromovinyl)2'-deoxy-L-uridine (L-BVDU): Selective Phosphorylation by Herpes Simplex Virus Type 1 Thymidine Kinase, Antiherpetic Activity and Cytotoxicity Studies. Mol. Pharmacol. 1995, 47, 12311238.
30. Pugmire, M. J.; Cook, W. J.; Jasanoff, A.; Walter, M. R.; Ealick, S. E. Structural and Theoretical Studies Suggest Domain Movement Produces an Active Conformation of Thymidine Phosphorylase. J. Mol. Biol. 1998,281, 285299.
31. Furukawa, T.; Yoshimura, A.; Sumizawa, T.; Haraguchi, M.; Akiyama, S.-I.; Fukui, K.; Ishizawa, M.; Yamada, K. Angiogenic Factor. Nature 1992, 356, 668.
32. Desgranges, C.; Razaka, G.; Rabaud, M.; Picard, P.; Dupuch, F.; Bricaud, H. The Human Blood Platelet: A Cellular Model to Study the Degradation of Thymidine and its Inhibition. Biochem. Pharmacol. 1982, 17, 2755-2759.
33. Usuki, K.; Norberg., L.; Larsson, E.; Miyazono, K.; Hellman, U. W., C.; Rubin, K.; Heldin, C.-H. Localization of Platelet-Derived Endothelial Cell Growth Factor in Human Placenta and Purification of an Alternatively Processed Form. Cell Regvl. 1990, 577596.
34. Yoshimura, A.; Kuwazuru, Y.; Furukawa, T.; Yoshida, H.; Yamada, K.; Akiyama, S. Purification and Tissue Distribution of Human Thymidine Phosphorylase: High Espression in Lymphocytes, Reticulocytes and Tumors. Biochim. Biophys. Acta l990, 1034, 107-113.
35. O'Brien, T.; Cranston, D.; Fuggle, S.; Biçknell, R.; Harris, A. L. Different Angiogenic Pathways Characterize Superficial and Invasive Bladder Cancer. Cancer Res. 1995, 55, 510-513.
36. Reynolds, K.; Farzaneh, F.; Collins, W. P.; Campbell, S.; Bourne, T. H.; Lawton, F.; Moghaddam, A.; Harris, A. L.; Biçknell, R. Association of Ovarian Malignancy with Expression of Platelet-Derived Endothelial Cell Growth Factor. J. Nail. Cancer Inst. 1994, 86, 1234-1238.
37. Fujimoto, K.; Hosotani, R.; Wada, M.; Lee, J. U.; Koshiba, T.; Miyamoto, Y.; Tsuji, S.; Nakajima, S.; Doi, R.; Imamura, M. Expression of two Angiogenic Factors, Vascular Endothelial Growth Factor and PlateletDerived Endothelial Cell Growth Factor in Human Pancreatic Cancer, and its Relationship to Angiogenesis. Etir. J. Cancer 1998, 34, 1439-1447.
38. Maeda, K.; Kang, S. M.; Ogawa, M.; Sawada, T.; Nakata, B.; Kato, Y.; Chung, Y. S.; Sowa, M. Combined Analysis of Vascular Endothelial Growth Factor and PlateletDerived Endothelial Cell Growth Factor Expression in Gastric Carcinoma. Int. J. Cancer 1997, 74, 545-550.
39. Saeki, T.; Tanada, M.; Takashima, S.; Saeki, H.; Takiyama, W.; Nishimoto, N.; Moriwaki, S. Correlation Between Expression of Platelt-Derived Endothelial Cell Growth Factor (Thymidine Phosphorylase) and Microvessel Density in Early-Stage Human Colon Carcinomas. Jpn. J. Clin. Oncol. 1997, 27, 227-230.
40. Hâta, K.; Hâta, T.; lida, K.; Miyazaki, K. Expression of Thymidine Phosphorylase in Uterine Sarcoma and Uterine Leiomyoma: Association with Microvessel Density and Doppler Blood Flow Analysis. Ultrasound Obstet. Gynecol. 1997, 10, 54-58.
41. Imazano, Y.; Takebayashi, Y.; Nishiyashi, K.; Akiba, S.; Miyadera, K.; Yamada, Y.; Akiyama, S.; Ohi, Y. Correlation Between Thymidine Phosphorylase Expression and Prognosis in Human Renal Cell Carcinoma. J. Clin. Oncol. 1997,15, 2570-2578.
42. Reif, M.; LeJeune, S.; Scott, P. A.; Fox, S.; Smith, K.; Moghaddam, A.; Whitehouse, R.; Bicknell, R.; Harris, A. L. Expression of the Angiogenic Factors Vascular Endothelial Cell Growth Factor, Acidic and Basic Fibroblast Growth Factor Beta-1, Platelet-Derived Endothelial Cell Growth Factor, Placenta Growth Factor, and Pleiotrophin in Human Primary Breast Cancer and its Relation to Angiogenesis. Cancer Res. 1997, 57, 963-969.
43. Giatromanolaki, A.; Koukourakis, M. I.; Comley, M.; Kaklamanis, L.; Turley, H.; O'Byrne, K.; Harris, A. L.; Gatter, K. C. Platelet-Derived Endothelial Cell Growth Factor (Thymidine Phosphorylase) Expression in Lung Cancer. J. Palhol. 1997, 757, 196-199.
44. Fox, S. B.; Westwood, M.; Moghaddam, A.; Comley, M.; Turley, H.; Whitehouse, R. M.; Bicknell, R.; Gatter, K. C.; Harris, A. L. The Angiogenic Factor Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase is Up-Regulated in Breast Cancer Epithelium and Endothelium. Br. J. Cancer 1996, 73, 275-280.
45. Yonenaga, F.; Takasaki, T.; Ohi, Y.; Sagara, Y.; Akiba, S.; Yoshinaka, H.; Aikou, T.; Miyadera, K.; Akiyama, S.; Yoshida, H. The Expression of Thymidine Phosphorylase/Platelet-Derived Endothelial Cell Growth Factor is Correlated to Angiogenesis in Breast Cancer. Pathol. Int. 1998, 48, 850-856.
46. Nakayama, Y.; Sueishi K; Oka K; Kono S; M., T. Stromal Angiogenesis in Human Glioma: A Role of PlateletDerived Endothelial Cell Growth Factor. Surg. Neural. 1998,49, 181-188.
47. Takano, S.; Tsuboi, K.; Matsumura, A.; Tomono, Y.; Mitsui, Y.; Nose, T. Expression of the Angiogenic Factor Thymidine Phosphorylase in Human Astrocytic Tumors. J. Cancer Res. Clin. Oncol. 2000, 726, 145-152.
48. Takahashi, Y.; Bucana, C D.; Liu, W.; Yoneda, J.; Kitadai, Y.; Cleary, K. R.; Ellis, L. M. Platelet-Derived Endothelial Cell Growth Factor in Human Colon Cancer Angiogenesis: Role of Infiltrating Cells. J. Natl. Cancer Inst.1996,88, 1146-1151.
49. Takeuchi, M.; Otsuka, T.; Matsui, N.; Asai, K.; Hirano, T.; Moriyama, A.; Isobe, I.; Eksioglu, Y. Z.; Matsukawa, K.; Kato, T. Aberrant Production of Gliostatin/PlateletDerived Endothelial Cell Growth Factor in Rheumatoid Synovium. Arthritis Rheum. 1994, 37, 662-672.
50. Creamer, D.; Jaggar, R.; Alien, M.; Bicknell, R.; Barker, J. Overexpression of the Angiogenic Factor PlateletDerived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Psoriatic Epidermis. Br. J. Dermatol. 1997,137, 851-855.
51. Kasugai, K.; Joh, T.; Kataoka, H.; Sasaki, M.; Tada, T.; Asai, K.;'Kato, T.; Itoh, M. Evidence For Participation of Gliostatin/Platelet-Derived Endothelial Cell Growth Factor in Gastric Ulcer Healing. Life Sei. 1997,61, 1899-1906.
52. Usuki, K.; Heldin, N.-E.; Miyazono, K.; Ishikawa, F.; Takaku, F.; Westermark, B.; Heldin, C.-H. Production of Platelet-Derived Endothelial Cell Growth Factor by Normal and Transformed Human Cells in Culture. Proc. Natl. Acad. Sei. USA 1989,56, 7427-7431.
53. Usuki, K.; Gonez, L. J.; Wernstedt, C.; Moren, A.; Miyazono, K.; Claesson-Welsh, L.; Heldin, C. H. Structural Properties of 3.0 kb and 3.2 kb Transcripts Encoding Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in A431 Cells. Biochim. Biophys. Acta 1994, 1222, 411-414.
54. Finkenzeller, G.; Sparacio, A.; Technau, A.; Marme, D.; Siemeister, G. Spl Recognition Sites in The Proximal Promoter of The Human Vascular Endothelial Growth Factor Gene are Essential Forplatelet-Derived Growth Factor-Induced Gene Expression. Oncogene 1997, 15, 669-676.
55. Goto, H.; Kohno, K.; Sone, S.; Akiyama, S.; Kuwano, M.; Ono, M. Interferon Gamma-Dependent Induction of Thymidine Phosphorylase/Platelet-Derived Endothelial Growth Factor Through Gamma-Activated SequenceLike Element in Human Macrophages. Cancer Res. 2001, 61, 469-473.
56. Schwanz, E. L.; Baptiste, N.; Megati, S.; VVadler, S.; Otter, B. A. 5-Ethoxy-2'-Deoxyuridine, a Novel Substrate for Thymidine Phosphorylase, Potentiates the Antitumor Activity of 5-Fluorouracil when Used in Combination with Interferon, an Inducer of Thymidine Phosphorylase Expression. Cancer Res. 1995, 55, 35433550.
57. Makower, D.; Wadler, S.; Haynes, H.; L., S. E. Interferon Induces Thymidine Phosphorylase/Platelet-Derived Endothelial Cell Growth Factor Expression In Vivo. Clin. Cancer Res. 1997, 3, 923-929.
58. Schwanz, E. L.; Wan, E.; Wang, F. S.; Baptiste, N. Regulation Of Expression Of Thymidine Phosphorylase/Platelet-Derived Endothelial Cell Growth Factor in Human Colon Carcinoma Cells. Cancer Res. 1998, 58, 1551-1557.
59. Usuki, K.; Miyazono, K.; Heldin, C.-H. Covalent Linkage Between Nucleotides and Platelet-Derived Endothelial Cell Growth Factor. J. Biol. Chem. 1991, 266, 20525-20531.
60. Asai, K.; Hirano, T.; Kaneko, S.; Moriyama, A.; Nakanishi, K.; Isobe, I.; Eksioglu, Y. Z.; Kato, T. A Novel Glial Growth Inhibitory Factor, Gliostatin, Derived from Neurofibroma. J. Neurochem. 1992, 59, 307-317.
61. Moghaddam, A.; Zhang, H. T.; Fan, T. P.; Hu, D. E.; Lees, V. C.; Turley, H.; Fox, S. B.; Gatter, K. C.; Harris, A. L.; Bicknell, R. Thymidine Phosphorylase is Angiogenic and Promotes Tumor Growth. Proc. Natl. Acad. Sei. USA 1995,92, 998-1002.
62. Miyadera, K.; Sumizawa, T.; Haraguchi, M.; Yoshida, H.; Konstanty, W.; Yamada, Y.; Akiyama, S. Role of Thymidine Phosphorylase Activity in the Angiogenic Effect of Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase. Cancer Res. 1995, 55, 1687-1690.
63. Haraguchi, M.; Miyadera, K.; Uemura, K.; Sumizawa, T.; Furukawa, T.; Yamada, K.; Akiyama, S.; Yamada, Y. Angiogenic Activity of Enzymes. Nature 1994, 368, 198.
64. Vogel, T.; Blake, D. A.; Whikehart, D. R.; Guo, N. H.; Zabrenetzky, V. S.; Roberts, D. D. Specific Simple Sugars Promote Chemotaxis and Chemokinesis of Corneal Endothelial Cells. J. Cell Physiol. 1993, 757, 359-366.
65. Brown, N. S.; Jones, A.; Fujiyama, C.; Harris, A. L.; Bicknell, R. Thymidine Phosphorylase Induces Carcinoma Cell Oxidative Stress and Promotes Secretion of Angiogenic Factors. Cancer Res. 2000, 60, 62986302.
66. Monnier, V. M. Non Enzymatic Glycosylation, the Maillard Reaction and the Aging Process. J. Gerontol. 1990, BIOS-Bill.
67. Kletsas, D.; Barbieri, D.; Stathakos, D.; Botti, B.; Bergamini, S.; Tomasi, A.; Monti, D.; Malorni, W.; Franceschi, C. The Highly Reducing Sugar 2-Deoxy-DRibose Induces Apoptosis in Human Fibroblasts by Reduced Glutathione Depletion and Cytoskeletal Disruption. Biochem. Biophys. Res. Commun. 1998, 243, 416-425.
68. Mignatti, P.; Rifkin, D. B. Plasminogen Activators and Matrix Metalloproteinases in Angiogenesis. Enzyme Protein 1996, 49, 117-137.
69. Ueki, T.; Nakanishi, K.; Asai, K.; Okouchi, Y.; Isobe, I.; Eksioglu, Y.; Kato, T.; Kohno, K. Neurotrophic Action of Gliostatin on Cocultured Neurons with Glial Cells. Brain Res. 1993, 622, 299-302.
70. Veres, Z.; Szabolcs, A.; Szinai, I.; Denes, G.; Jeney, A. Enzymatic Cleavage of 5-Substituted-2'-Deoxyuridines by Pyrimidine Nucleoside Phosphorylases. Biochem. Pharmacol. 1986, 35, 1057-1059.
71. el Kouni, M. H.; el Kouni, M. M.; Naguib, F. N. Differences in Activities and Substrate Specificity of Human and Murine Pyrimidine Nucleoside Phosphorylases: Implications for Chemotherapy with 5Fluoropyrimidines. Cancer Res. 1993, 53, 3687-3693.
72. Haraguchi, M.; Furukawa, T.; Sumizawa, T.; Akiyama, S. Sensitivity of Human KB Cells Expressing PlateletDerived Endothelial Cell Growth Factor to Pyrimidine Antimetabolites. Cancer Res. 1993, 53, 5680-5682.
73. Eda, H.; Fujimoto, K.; Watanabe, S.; Ura, M.; Hino, A.; Tanaka, Y.; Wada, K.; Ishitsuka, H. Cytokines Induce Thymidine Phosphorylase Expression in Tumor Cells and Make them More Susceptible to 5'-Deoxy-5fluorouridine. Cancer Chemother. Pharmacol. 1993, 32, 333-338.
74. Schwartz, E. L.; Baptiste, N.; Wadler, S.; Makower, D. Thymidine Phosphorylase Mediates the Sensitivity of Human Colon Carcinoma Cells to 5-Fluorouracil. J. Biol. Chem. 1995, 270, 19073-19077.
75. Makower, D.; Wadler, S.; Haynes, H.; Schwartz, E. L. Interferon Induces Thymidine Phosphorylase/PlateletDerived Endothelial Cell Growth Factor Expression In Vivo. Clin. Cancer Res. 1997, 3, 923-929.
76. Makower, D.; Wadler, S. Interferons as Biomodulators of Fluoropyrimidines in the Treatment of Colorectal Cancer. Semin. Oncol. 1999,26, 663-671.
77. Langen, P.; Etzold, G.; Bärwolff, D.; Preusel, B. Inhibition of Thymidine Phosphorylase by 6Aminothymine and Derivatives of 6-Aminouracil. Biochem. Pharmacol. 1967,16, 1833-1837.
78. Balzarini, J.; Gamboa, A. E.; Esnouf, R.; Liekens, S.; Neyts, J.; De Clercq, E.; Camarasa, M.-J.; Perez-Perez, M.J. 7-Deazaxanthine, a Novel Prototype Inhibitor of Thymidine Phosphorylase. FEES Lett. 1998, 438, 9195.
79. Matsushida, S.; Nitanda, T.; Furukawa, T.; Sumizawa, T.; Tani, A.; Nishimoto, K.; Akiba, S.; Miyadera, K.; Fukushima, M.; Yamada, Y.; Yoshida, H.; Kanzaki, T.; Akiyama, S. The Effect of a Thymidine Phosphorylase Inhibitor on Angiogenesis and Apoptosis in Tumor. Cancer Res. 1999, 59, 1911-1916.
80. Focher, F.; Spadari, S.; Ubiali, D.; Pregnolato, M.; Zhi, C.; Gambino, J.; Wright, G. E. Novel Non-Substrate Inhibitors of Human Thymidine Phosphorylase, a Potential Target for Tumor-Dependent Angiogenesis. J. Med. Chem. 2000, 43, 2601-2607.
81. Esteban-Gamboa, A.; Balzarini, J.; Esnouf, R.; De Clercq, E.; Camarasa, M. J.; Perez-Perez, M. J. Design, Synthesis, and Enzymatic Evaluation of Multisubstrate Analogue Inhibitors of Escherichia Coli Thymidine Phosphorylase. J. Med. Chem.2000,43, 971-983.
82. Baizarini, J.; Dégrevé, B.; Esteban-Gamboa, A.; Esnouf, R.; De Clercq, E.-; Engelborghs, Y.; Camarasa, M. J.; Perez-Perez, M. J. Kinetic Analysis of Novel . Multisubstrate Analogue Inhibitors of Thymidine Phosphorylase. FEBS Lett. 2000, 483, 181-185.
83. Takao, S.; Akiyama, S. I.; Nakajo, A.; Yoh, H.; Kitazono, M.; Natsugoe, S.; K., M.; Fukushima, M.; Yamada, Y.; Aikou, T. Suppression of Metastasis by Thymidine Phosphorylase Inhibitor. Cancer Res. 2000, 60, 53455348.
84. Bardosi, A.; Creutzfeldt, W.; DiMauro, S.; Felgenhauer, K.; Friede, R. L.; Goebel, H. H.; Kohlschutter, A.; Mayer, G.; Rahlf, G.; Servidei, S. Myo-, Neuro-, Gastrointestinal Encephalopathy (MNGIE Syndrome) Due to Partial Deficiency of Cytochrome-C-Oxidase. A New Mitochondrial Multisystem Disorder. Ac t a Neuropathol. 1987, 74, 248-258.
85. Hirano, M.; Silvestri, G.; Blake, D. M.; Lombes, A.; Minetti, C.; Bonilla, E.; Hays, A. P.; Lovelace, R. E.; Butler, I.; Bertorini, T. E. Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): Clinical, Biochemical, and Genetic Features of an Autosomal Recessive Mitochondrial Disorder. Neurology 1994, 44, 721-727.
86. Papadimitriou, A.; Comi, G. P.; Hadjigeorgiou, G. M.; Bordoni, A.; Sciacco, M.; Napoli, L.; Prelle, A.; Moggio, M.; Fagiolari, G.; Bresolin, N.; Salani, S.; Anastasopoulos, I.; Giassakis, G.; Divari, R.; Scarlato, G. Partial Depletion and Multiple Deletions of Muscle MtDNA in Familial MNGIE Syndrome. Neurology 1998,57, 1086-1092.
87. Nishino, I.; Spinazzola, A.; Hirano, M. Thymidine Phosphorylase Gene Mutations in MNGIE, a Human Mitochondrial Disorder. Science 1999, 283, 689-692.
88. Nishino, I.; Spinazzola, A.; Papadimitriou, A.; Hammans, S.; Steiner, L; Hahn, C. D.; Connolly, A. M.; Verloes, A.; Guimaraes, J.; Maillard, I.; Hamano, H.; Donati, M. A.; Semrad, C. E.; Russell, J. A.; Andreu, A. L.; Hadjigeorgiou, G. M.; Vu, T. H.; Tadesse, S.; Nygaard, T. G.; Nonaka, L; Hirano, L; Bonilla, E.; Rowland, L. P.; DiMauro, S.; Hirano, M. Mitochondrial Neurogastrointestinal Encephalomyopathy: An Autosomal Recessive Disorder due to Thymidine Phosphorylase Mutations. Ann. Neural. 2000, 47, 792800.
89. Nishino, L; Spinazzola, A.; Hirano, M. MNGIE: from Nuclear DNA to Mitochondrial DNA. Neuromuscul. Disord.2001,11, 7-10.
90. Hirano, M.; Vu, T. H. Defects of Intergenomic Communication: Where do we Stand? Brain Pathol. 2000,10, 451-461.